India Vaccine Maker Is Still Testing AstraZeneca’s Shot After Firm Halts Trials

(Bloomberg) -- The Indian company enlisted to manufacture a billion doses of AstraZeneca Plc’s experimental Covid-19 vaccine is pushing ahead with its own clinical trial even as safety concerns for...